Production (Stage)
Eastgate Biotech Corp.
ETBI
$0.0001
-$0.0039-97.50%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | 8.41% | -13.89% | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -51.83% | 1,205.93% | -13.89% | -- | 109.47% |
|
|
|||||
| Total Current Assets | -51.83% | 1,205.93% | -13.89% | -- | 109.47% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 238.63% | 2,371.72% | -13.89% | -- | 35.23% |
|
|
|||||
| Total Accounts Payable | 143.14% | 62.08% | 57.39% | -22.54% | -20.30% |
| Total Accrued Expenses | 41.00% | 55.97% | 77.29% | 146.74% | 365.98% |
| Short-term Debt | 79.23% | 60.75% | 26.61% | 27.31% | 17.41% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3,628.71% | 178.82% | 19.54% | 28.40% | 32.89% |
| Total Finance Division Other Current Liabilities | 0.42% | -0.84% | 230.99% | 259.46% | 3,724.00% |
| Total Other Current Liabilities | 0.42% | -0.84% | 230.99% | 259.46% | 3,724.00% |
| Total Current Liabilities | 69.62% | 57.15% | 54.40% | 67.78% | 94.65% |
|
|
|||||
| Total Current Liabilities | 69.62% | 57.15% | 54.40% | 67.78% | 94.65% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 79.23% | 60.75% | 26.61% | 27.31% | 17.41% |
| Capital Leases | -- | -- | -16.32% | -20.63% | -21.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 67.92% | 55.14% | 53.35% | 66.18% | 91.83% |
|
|
|||||
| Common Stock & APIC | 33.71% | 23.46% | 7.44% | 9.11% | 9.86% |
| Retained Earnings | -30.85% | -19.94% | -18.80% | -25.55% | -29.87% |
| Treasury Stock & Other | -643.50% | 229.94% | 76.54% | 24.84% | -11.16% |
| Total Common Equity | -27.63% | -9.47% | -53.58% | -86.13% | -130.77% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -27.63% | -9.47% | -53.58% | -86.13% | -130.77% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -27.63% | -9.46% | -53.58% | -86.13% | -130.77% |
|
|
|||||